Notice ID: d50ba2f2eb5a4791a7ce9e599cc69cbfSpecial Notice
6550--Notice of Intent to Sole-Source T-SPOT.TB® Reagents and Kits
Archived on October 31, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 4:00 PM EDT
- Posted
- October 2, 2026
- Notice type
- Special Notice
Notice details
- Office
- 242-NETWORK CONTRACT OFFICE 02 (36C242)
- Last updated
- Oct 31, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 36C24227Q0036
- Notice ID
- d50ba2f2eb5a4791a7ce9e599cc69cbf
Description
This notice is being published in accordance with Revolutionary FAR Overhaul Federal Acquisition Regulation (RFO FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. The Department of Veterans Affairs, Network Contracting Office (NCO) 2, hereby provides notice of its intent to award a sole source, firm fixed price contract to Euroimmun US Incorporated, the sole authorized U.S. distributor of T SPOT.TB® reagents and associated kits manufactured by Oxford Immunotec. These reagents are required for tuberculosis testing at VA Western New York Healthcare System (VAWNYHS) Buffalo VA Medical Center (VAMC). This determination is made in accordance with RFO FAR 12.201-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The T SPOT.TB® assay is a patented IGRA platform, and its reagents including the antigen panels, controls, and AIM V media are proprietary and FDA cleared only for use with the OEM platform. Oxford Immunotec holds the exclusive patent rights, and Euroimmun US Incorporated is the only supplier legally authorized to provide these FDA approved reagents for federal healthcare facilities. No other vendor can supply reagents that meet FDA, CLIA, CAP, and Joint Commission requirements. This notice is not a request for competitive quotes. However, interested parties may identify their interest and capability to respond to this requirement by submitting a: Capability Statement (1 page maximum) Company Name UEI Number Socioeconomic Status Proof of authorization to provide the OEM reagents Responses must be received no later than 4:00 PM EST on October 16, 2026 to Myra.Green2@va.gov A determination not to compete this proposed action is solely within the discretion of the Government. Information received will only be considered for determining whether to conduct a competitive procurement in the future. Prospective contractors must be registered in SAM.gov to be eligible for award.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Myra F. Green
Contracting Officer
Documents
Files (2)
Links (1)
- New York/New Jersey VA Health Care Networkvaww.visn2.va.govPosted
Lifecycle
- 1Version 1Special NoticeCurrent
6550--Notice of Intent to Sole-Source T-SPOT.TB® Reagents and Kits
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36C24227Q0036
Archive Date
Oct 31, 2026
Office Address
ALBANY, NY, 12208